Literature DB >> 22973424

Herpesvirus infections of the central nervous system in immunocompromised patients.

Uta Meyding-Lamadé1, Cornelia Strank.   

Abstract

Human herpesviruses may cause infections of the central nervous system during primary infection or following reactivation from a latent state. Especially in immunosuppressed patients the infection can take a life-threatening course, and therefore early diagnosis of herpesvirus-associated neurological diseases should have high priority. Clinical presentation in these patients is usually without typical features, making diagnosis even more challenging. Therefore general broad testing for different herpesviruses in cerebrospinal fluid samples is highly recommended. In addition, determination of the virus DNA level in the cerebrospinal fluid by quantitative assays seems to be of high importance to determine prognosis. Moreover, it might help to differentiate between specific virus-associated disease and unspecific presence of virus in the cerebrospinal fluid, especially in immunocompromised patients. Polymerase chain reaction analysis of cerebrospinal fluid has revolutionized the diagnosis of nervous system viral infections, particularly those caused by human herpesviruses. This review summarizes the role human herpesviruses play in central nervous system infections in immunocompromised patients, with a focus on the clinical manifestation of encephalitis.

Entities:  

Keywords:  Epstein-Barr virus; central nervous system; cytomegalovirus; herpes simplex virus; herpes viruses; human herpesvirus 6; immunocompromised; varicella-zoster virus

Year:  2012        PMID: 22973424      PMCID: PMC3437531          DOI: 10.1177/1756285612456234

Source DB:  PubMed          Journal:  Ther Adv Neurol Disord        ISSN: 1756-2856            Impact factor:   6.570


  123 in total

1.  Failure of high dose 5-iodo-2'-deoxyuridine in the therapy of herpes simplex virus encephalitis. Evidence of unacceptable toxicity.

Authors: 
Journal:  N Engl J Med       Date:  1975-03-20       Impact factor: 91.245

2.  Dementia following herpes zoster encephalitis.

Authors:  Katherine J Bangen; Lisa Delano-Wood; Christina E Wierenga; Nikki H Stricker; John R Hesselink; Mark W Bondi
Journal:  Clin Neuropsychol       Date:  2010-05-24       Impact factor: 3.535

3.  Varicella-zoster virus (VZV) DNA in cerebrospinal fluid of patients infected with human immunodeficiency virus: VZV disease of the central nervous system or subclinical reactivation of VZV infection?

Authors:  P Cinque; S Bossolasco; L Vago; C Fornara; S Lipari; S Racca; A Lazzarin; A Linde
Journal:  Clin Infect Dis       Date:  1997-09       Impact factor: 9.079

4.  Activity and safety of pegylated liposomal doxorubicin as first-line therapy in the treatment of non-visceral classic Kaposi's sarcoma: a multicenter study.

Authors:  Giuseppe Di Lorenzo; Alexander Kreuter; Rossella Di Trolio; Attilio Guarini; Carmela Romano; Vincenzo Montesarchio; Norbert H Brockmeyer; Sabino De Placido; Mark Bower; Bruce J Dezube
Journal:  J Invest Dermatol       Date:  2008-01-10       Impact factor: 8.551

5.  First report of successful treatment of multidrug-resistant cytomegalovirus disease with the novel anti-CMV compound AIC246.

Authors:  D R Kaul; S Stoelben; E Cober; T Ojo; E Sandusky; P Lischka; H Zimmermann; H Rubsamen-Schaeff
Journal:  Am J Transplant       Date:  2011-05       Impact factor: 8.086

Review 6.  Antiviral agents active against human herpesviruses HHV-6, HHV-7 and HHV-8.

Authors:  E De Clercq; L Naesens; L De Bolle; D Schols; Y Zhang; J Neyts
Journal:  Rev Med Virol       Date:  2001 Nov-Dec       Impact factor: 6.989

7.  Defective regulation of Epstein-Barr virus infection in patients with acquired immunodeficiency syndrome (AIDS) or AIDS-related disorders.

Authors:  D L Birx; R R Redfield; G Tosato
Journal:  N Engl J Med       Date:  1986-04-03       Impact factor: 91.245

8.  Prevalence and distribution of human herpesvirus 6 variants A and B in adult human brain.

Authors:  P K Chan; H K Ng; M Hui; A F Cheng
Journal:  J Med Virol       Date:  2001-05       Impact factor: 2.327

Review 9.  Diagnosis of herpesvirus infections of the central nervous system.

Authors:  Guy Boivin
Journal:  Herpes       Date:  2004-06

10.  Human herpesvirus 6 and multiple sclerosis: a study of T cell cross-reactivity to viral and myelin basic protein antigens.

Authors:  Mara Cirone; Laura Cuomo; Claudia Zompetta; Stefano Ruggieri; Luigi Frati; Alberto Faggioni; Giuseppe Ragona
Journal:  J Med Virol       Date:  2002-10       Impact factor: 2.327

View more
  21 in total

1.  Presumptive human herpesvirus 6 myelopathy in an immunocompetent patient.

Authors:  Roger E Kelley; Joseph R Berger; Mary Espey; Brian P Kelley
Journal:  J Neurovirol       Date:  2014-11-04       Impact factor: 2.643

2.  [Fulminant EBV meningoencephalitis : Good clinical outcome in a young, immunocompetent female].

Authors:  F Derler; S Seidel; D Bengel
Journal:  Nervenarzt       Date:  2017-10       Impact factor: 1.214

Review 3.  CNS Infections in Immunoincompetent Patients : Neuroradiological and Clinical Features.

Authors:  Stefan Weidauer; Marlies Wagner; Simon Jonas Enkirch; Elke Hattingen
Journal:  Clin Neuroradiol       Date:  2019-09-19       Impact factor: 3.649

4.  Detection frequency of human herpesviruses-6A, -6B, and -7 genomic sequences in central nervous system DNA samples from post-mortem individuals with unspecified encephalopathy.

Authors:  Svetlana Chapenko; Silvija Roga; Sandra Skuja; Santa Rasa; Maksims Cistjakovs; Simons Svirskis; Zane Zaserska; Valerija Groma; Modra Murovska
Journal:  J Neurovirol       Date:  2016-01-04       Impact factor: 2.643

5.  Prevalence of human Herpesviridae in cerebrospinal fluid of patients with multiple sclerosis and noninfectious neurological disease in the Netherlands.

Authors:  Gijsbert P van Nierop; Rogier Q Hintzen; Georges M G M Verjans
Journal:  J Neurovirol       Date:  2014-03-27       Impact factor: 2.643

Review 6.  Immunomodulatory roles of human herpesvirus-encoded microRNA in host-virus interaction.

Authors:  Afsar R Naqvi
Journal:  Rev Med Virol       Date:  2019-08-20       Impact factor: 6.989

7.  Virological diagnosis of central nervous system infections by use of PCR coupled with mass spectrometry analysis of cerebrospinal fluid samples.

Authors:  Nicolas Lévêque; Jérôme Legoff; Catherine Mengelle; Séverine Mercier-Delarue; Yohan N'guyen; Fanny Renois; Fabien Tissier; François Simon; Jacques Izopet; Laurent Andréoletti
Journal:  J Clin Microbiol       Date:  2013-11-06       Impact factor: 5.948

8.  Advances in Infectious Encephalitis: Etiologies, Outcomes, and Potential Links with Anti-NMDAR Encephalitis.

Authors:  Arun Venkatesan
Journal:  Curr Infect Dis Rep       Date:  2013-12       Impact factor: 3.725

9.  Optimisation of a quantitative polymerase chain reaction-based strategy for the detection and quantification of human herpesvirus 6 DNA in patients undergoing allogeneic haematopoietic stem cell transplantation.

Authors:  Miriam Y H Ueda; Paulo G Alvarenga; Juliana M Real; Eloisa de Sá Moreira; Aripuanã Watanabe; Ana Maria Passos-Castilho; Matheus Vescovi; Yana Novis; Vanderson Rocha; Adriana Seber; Jose S R Oliveira; Celso A Rodrigues; Celso F H Granato
Journal:  Mem Inst Oswaldo Cruz       Date:  2015-06-02       Impact factor: 2.743

Review 10.  Neurotropic virus infections as the cause of immediate and delayed neuropathology.

Authors:  Martin Ludlow; Jeroen Kortekaas; Christiane Herden; Bernd Hoffmann; Dennis Tappe; Corinna Trebst; Diane E Griffin; Hannah E Brindle; Tom Solomon; Alan S Brown; Debby van Riel; Katja C Wolthers; Dasja Pajkrt; Peter Wohlsein; Byron E E Martina; Wolfgang Baumgärtner; Georges M Verjans; Albert D M E Osterhaus
Journal:  Acta Neuropathol       Date:  2015-12-10       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.